Skip to main content
PLOS One logoLink to PLOS One
. 2025 Oct 6;20(10):e0333793. doi: 10.1371/journal.pone.0333793

Effect of fluid intake on cognitive function in older individuals: A prospective study

Hideyuki Hoshi 1, Yusuke Kakubari 2, Emi Moriya 3, Keita Shinada 2, Yoshihito Shigihara 1,*
Editor: Tanja Grubić Kezele4
PMCID: PMC12500155  PMID: 41052096

Abstract

Background

Adequate fluid intake is essential for maintaining cognitive health in older adults. However, two key questions remain unanswered before recommending increased fluid consumption: (1) whether the relationship between fluid intake and cognitive improvement is linear and (2) the underlying mechanisms that mediate this association.

Methods and Findings

Thirty-three older adults residing in a geriatric health service facility and receiving nursing care were enrolled in this study. Fluid intake was recorded as part of routine clinical practice. Cognitive function was assessed twice during their stay using the Japanese version of the Mini-Mental State Examination (MMSE-J). Additionally, cerebral blood flow was evaluated bilaterally in the common carotid arteries using ultrasonography, with assessments conducted approximately 82.6 ± 14.9 days apart. Relationships among fluid intake per lean body mass (LBM), changes in MMSE-J scores, and ultrasonographic parameters were analysed using Spearman’s linear correlation analysis with non-parametric bootstrapping. Correlation analyses revealed a positive linear association between fluid intake and improvement in MMSE-J scores [P(FDR) = 0.012] when the intake was less than 42 mL/LBM (kg) per day. Furthermore, fluid intake was inversely correlated with the resistance index in the right common carotid artery [P(FDR) = 0.046], indicating altered cerebral blood dynamics. The main limitations of our study include (1) the inability to evaluate baseline hydration status or fluid intake prior to facility admission due to clinical constraints and (2) the observational design precluding causal inference between fluid intake, cognitive changes, and cerebral blood flow parameters.

Conclusions

Within moderate intake ranges, fluid consumption was linearly associated with cognitive improvement, an effect that appears to be mediated by changes in cerebral haemodynamic.

Introduction

Cognitive impairment, such as dementia, represents a significant concern among older adults [1]. Such impairment adversely affects daily functioning and reduces quality of life [2,3]. Although typically progressive over time [4,5], cognitive decline is not always irreversible [6,7], as it can be influenced by various modifiable lifestyle factors [811]. Identifying optimal lifestyle practices for preserving cognitive function is therefore essential. Among these factors, fluid intake (FI)—including the consumption of water—has been recognised as a key determinant of cognitive health. Previous studies have shown that dehydration (i.e., a deficit in total body fluid [1215]) negatively impacts cognitive performance [14,1619], whereas maintaining adequate dehydration supports cognitive function. However, all older adults are particularly susceptible to dehydration [12,20] due to age-related physiological changes [12,19,21]. These include impaired regulation of water balance, reduced insensitivity to thirst, decreased total body water reserves, and the use of medications with diuretic properties [12,15,19,22]. The prevalence of dehydration among community-dwelling older adults ranges from 1% to 60% [20]. Dehydration events occurred in 31% of nursing home residents over 6 months [23]. These findings suggest that dehydration is both common and consequential in this population, contributing to cognitive decline that may otherwise be preventable. Therefore, encouraging adequate fluid intake among older adults remains essential. The European Food Safety Authority (EFSA) recommends a total daily water intake of 2,000 mL per day for women and 2,500 mL per day for men derived from drinking water, beverages, and food across all age groups [24]. Given that approximately 20% of total water intake is derived from food, the recommended fluid intakes from beverages alone are adjusted to 1,600 mL per day for women and 2,000 mL per day for men [12]. However, clinicians often express caution in recommending substantial increases in FI among older adults, given the prevalence of heart failure risk in this population [2527]. Several clinical guidelines advise against excessive FI to reduce the risk of fluid overload and subsequent cardiac decompensation [2830]. Excessive expansion of blood volume may lead to a reduction in cardiac output [3133], and diminished cerebral perfusion resulting from impaired circulation has been associated with cognitive decline [3436] (Fig 1B). Encouraging increased FI among older adults to support cognitive function requires evidence demonstrating an association between higher FI and cognitive improvement (Theme 1 in Fig 1) and clear explanations of the underlying mechanisms linking FI to cognitive improvement (Theme 2 in Fig 1).

Fig 1. Study design.

Fig 1

(A) Study protocol. Cognitive function and cerebral blood dynamics were assessed twice for each participant (first and second assessments). Assessment intervals varied due to clinical constraints. As part of routine clinical care, participants were advised to consume 1,500 mL of fluid per day. (B) Expected relationship between fluid intake and cognitive change. A positive association was anticipated between fluid intake and cognitive improvement, provided that excessive intake does not result in adverse effects (yellow-shaded range). This expectation was based on the known relationship between blood volume and cardiac output in patients with heart failure. (C) Study hypothesis. Adequate fluid intake was hypothesised to alleviate dehydration, enhance cerebral blood dynamics, and promote cognitive improvement within the yellow-shaded range. Blue boxes illustrate the components of the hypothesis.

This study hypothesised that adequate FI would alleviate dehydration, enhance cerebral blood dynamics, and contribute to cognitive improvement (Blue boxes in Fig 1C), provided that excessive FI does not produce adverse effects (Fig 1B). To test this hypothesis, the relationship between daily FI and changes in cognitive function was examined using clinical records from older participants residing in a geriatric health service facility (Theme 1 in Fig 1). Additionally, carotid blood flow was assessed using ultrasonography to assess cerebral blood dynamics and to investigate potential mechanisms linking increased FI with cognitive improvement (Theme 2 in Fig 1).

Materials and methods

Patients and ethics

Thirty-three participants (21 women; mean age ± standard deviation, 86.5 ± 8.0 years [range: 60–100 years]) who received nursing care at the geriatric health service facility ‘Kakehashi’ were enrolled in the present study. Participants presented with various chronic conditions: dementia (n = 9), disuse syndrome (n = 3), fractures (n = 3), Parkinson’s disease (n = 2), and other individual diagnoses. Detailed diagnostic and demographic information is provided in Table 1. No additional pharmacological treatments targeting cognition were administered; in accordance with the general care approach of the Japanese geriatric health service facility, which emphasises non-pharmacological interventions. Patients who (1) were admitted to the facility to receive nursing care between 12 May 2022 and 23 May 2023 and (2) agreed to participate in the present study were analysed. Meanwhile, patients with a history of stroke were excluded. This study was approved by the Ethics Committee of Hokuto Hospital (#1099). All data used in the present study were anonymised at the initial stage of collection. Only two authors (YK and YS) retained the capacity to identify individuals through comparative tables, if required. Data were accessed for research purposes between 12 May 2022 and 2 May 2024. All protocols were performed in accordance with relevant Japanese guidelines and regulations. Written informed consent was obtained from all participants with intact cognitive function prior to enrolment. For those with cognitive impairment, consent was provided by their legal guardians (i.e., their family members). Decisions made by legal guardians on behalf of the participants were fully respected. This procedure was conducted in accordance with the Ethical Guidelines for Medical, Health Research Involving Human Subjects issued by the Japanese Ministry of Education, Culture, Sports, Science, and Technology.

Table 1. Participant characteristics and assessment dates relative to admission.

Ultrasonography
/cognitive status
Fluid intake data
ID Sex Age Diagnosis 1st 2nd Interval From To Duration
0001* F 94 Dyslipidaemia 1 120 119 1 119 118
0002* F 89 Dementia due to Alzheimer’s disease 4 95 91 1 94 93
0003 F 84 Dementia due to Alzheimer’s disease 7 2 55 53
0004 M 93 Traumatic haemothorax 0 89 89 1 90 89
0005 F 96 Dementia 4 100 96 1 104 103
0006 F 88 Geriatric psychosis 0 1 32 31
0007 F 81 Parkinson’s disease 12 90 78 1 90 89
0008 M 83 Cubital tunnel syndrome 12 90 78 1 90 89
0009 M 97 Aspiration pneumonia 3 93a 90 1 90 89
0010 F 84 Dementia 2a 93 91 1 88 87
0011 F 90 Hypoxemia 1 86 85 1 88 87
0012 F 67 Parkinson’s disease 2 87 85 1 88 87
0013 M 85 Fracture 16a 93a 77 2 87 85
0015 F 87 Aplastic anaemia 7 92a 85 1 87 86
0016 F 60 Dementia due to Alzheimer’s disease 0 85 85 1 87 86
0017 M 87 Dementia with Lewy bodies 6
0018 F 86 Chronic renal failure 3 94 91 1 90 89
0019 M 85 Brain tumour (post-operative) 1 92 91 1 90 89
0020 F 81 Bacterial pneumonia 9 86 77 2 90 88
0021 F 90 Dementia due to Alzheimer’s disease 8a 89b 81 1 90 89
0022 M 90 Aspiration pneumonia, Parkinson’s disease 3 94a 91 2 89 87
0023 F 86 Rheumatoid arthritis 1 35a 34 1 43 42
0024 M 84 Disuse syndrome 15 93 78 1 89 88
0025 M 88 Chronic heart failure 12 105 93 1 89 88
0026 F 95 Myofascial pain syndrome 15b 85 70 0 89 89
0027 F 100 Disuse syndrome 14a 61a 47 1 64 63
0028 F 80 Disuse syndrome 8 78 70 1 83 82
0029 M 94 Fracture (post-operative) 4 95 91 1 90 89
0030* F 92 Fracture 3 93 90 1 90 89
0031 M 91 Dementia due to Alzheimer’s disease 12 105 93 1 90 89
0032 M 82 Lower limb amputation 10a 103a 93 1 90 89
0033 F 77 Dementia, fracture 4 81a 77 1 81 80
0034 F 90 Anxiety disorder 3 80 77 2 87 85
M 86.6 6.1 88.9 82.6 1.13 85.1 84.0
SD 7.9 5.0 14.1 14.9 0.41 15.8 15.8
MIN 60 0 35 34 0 32 31
MAX 100 16 120 119 2 119 118

Unit: days; participants with an asterisk (*) in their IDs were excluded from the analysis of the changes due to being identified as outliers; amissing data on body fat percentage/LBM; bmissing FAB data; empty cell indicates all relevant data are missing; mnFI, amount of fluid intake normalised using lean body mass and averaged across study period; LBM, lean body mass; FAB, Frontal Assessment Battery; M, mean; SD, standard deviation

Study protocol and measurements

The participants remained at the facility for several months, with the duration of stay determined by medical and social factors and relevant regulations. The present study did not influence either the length of stay or the treatments provided, including the amount of FI. Cognitive status and cerebral blood dynamics were assessed twice during the stay. The first assessment was conducted early during their stay (6.1 ± 5.0 days after admission; range: 0–16 days), when their conditions were expected to be relatively unaffected by nursing care (Fig 1 and Table 1). The second assessment was conducted several months after admission, when the nursing care was expected to have influenced their condition. The timing of this assessment was determined based on clinical convenience. The average interval between the first and second assessments was 82.6 ± 14.9 days (range: 34–119 days). Although the intended interval was approximately 90 days, variations occurred due to clinical limitations and constraints.

As a clinical recommendation at the facility, all older individuals staying there were advised to consume as much fluid as possible, with a target of 1,500 mL per day. Fluids (e.g., water or green tea) were provided in scaled cups by staff members (including nurses, therapists, and care workers) at the bedside and in the dining areas during meals and upon request. The amount of fluid consumed was recorded by staff in the clinical records as part of routine clinical practice. Records were retrieved to cover the period between the first and second assessments as closely as possible (Table 1). As the impact of FI on the body varies according to individual body composition—specifically lean body mass (LBM)—FI was adjusted per participant’s LBM. This adjustment reflects the fact that approximately three-quarters of the total body water is distributed within LBM [3739]. Thus, FI was adjusted by each participant’s LBM. LBM was calculated using participants’ body weight and body fat percentage, each measured twice. The initial bodily profile assessment was conducted within one week of admission. Subsequent measurements were recorded monthly, with the record closest to the date of the second assessment (i.e., the day of cognitive and cerebral blood dynamics measurements) designated as the second bodily profile. Body weight and body fat percentage were obtained using a household body fat scale (HBF-306-A; OMRON Corporation, Kyoto, Japan). Daily FI was normalised using the participants’ LBM, which was calculated for the first and second bodily profile assessments (LBM1 and LBM2) using the following formula: (body weight) × (100 − body fat percentage) × 0.01. Daily LBM was estimated by linearly interpolating between LBM1 and LBM2. Normalised FI (nFI) was calculated by dividing the daily FI by the LBM. The unit of nFI is mL/LBM (kg) per day, representing the amount of FI per kg of LBM per day. The nFI values were averaged across the study period to obtain the mean normalised fluid intake (mnFI), which was used for the statistical analysis. Notably, body fat percentage data were missing for five participants at the first assessment and nine participants at the second assessment. Therefore, the mnFI was not computed for 11 participants who lacked body fat percentage data in either or both assessments.

Cognitive status was assessed twice—on the first and second assessment days (Fig 1)—using the Japanese version of the Mini-Mental State Examination (MMSE-J) [40] and the Frontal Assessment Battery (FAB) [41]. The MMSE is the most commonly used tool for dementia screening [42], primarily evaluating learning and memory performance [43]. The MMSE-J is equivalent to the original English version, with official test materials obtained from an authorised vendor (Success Bell, Edajima, Japan). The FAB is a concise neuropsychological assessment specifically designed to evaluate frontal lobe function [41], where MMSE shows lower sensitivity [44]. The MMSE-J and FAB are scored on scales of 0–30 and 0–18, respectively; lower scores indicate more severe cognitive impairment in both tests. These two assessments were selected for this study for two primary reasons. First, the MMSE-J is routinely administered in the facility as a part of standard clinical practice. Although MMSE is effective for evaluating global cognition [42], it is less sensitive to certain cognitive domains, such as frontal lobe functions [44]. To address this limitation, the FAB was employed, as clinical staff at the facility are experienced in its administration. Second, the neuropsychological assessments must be concise and time-efficient, as they were conducted by therapists during their demanding clinical duties. The MMSE-J score was unavailable for one participant at the second assessment, whereas the FAB scores were missing for one and two participants at the first and second assessments, respectively, due to clinical constraints.

Cerebral blood dynamics were assessed twice— on the same day as the cognitive assessments (first and second assessment days in Fig 1)—by a clinical laboratory technician (E.M.) using one of two ultrasonography devices: the ACUSON SC2000 (Siemens Healthineers, Erlangen, Germany) or the Viamo sv7 (Canon Medical Systems Corporation, Tochigi, Japan). Ultrasonography was selected over other neuroimaging techniques, such as functional magnetic resonance imaging or magnetoencephalography, owing to its feasibility for bedside use within the facility. A previous study demonstrated that ultrasonographic parameters are associated with resting-state brain activity, which is associated with cognitive function as assessed by neuropsychological tests [18]. The data acquisition procedures adhered to the methodology described in that study [18]. Four ultrasonographic parameters were measured from the left and right common carotid arteries (CCAs): diameter of the artery (DA), peak systolic flow velocity (PSV), end-diastolic velocity (EDV), and resistance index (RI). Mean velocity and pulsatility index, although assessed in the previous study, were not measured in the present study owing to technical limitations [18]. To distinguish between the measurement sides, the parameters were denoted with the prefix l (left) or r (right), such as lPSV and rRI. Ultrasonographic measurements were not performed in the three participants during the second assessment owing to their clinical conditions.

In this manuscript, the parameters measured twice [ultrasonographic parameters (i.e., cerebral blood dynamics), cognitive parameters (i.e., cognitive status), and bodily profiles, except daily fluid intake] are denoted with postfixes indicating the timing of the assessments: 1 (first assessment), 2 (second assessment), and c (change between the two assessments). For example, MMSE-J1 refers to the MMSE-J score obtained at the first assessment, lPSV2 refers to the PSV in the left CCA measured at the second assessment, and MMSE-Jc refers to the changes in MMSE-J scores between the first and second assessments. Some data were missing due to clinical limitations and constrains. These include cases where the second assessment had not been completed by the end of the data collection period (23 May 2023) or cases when assessments could not be conducted due to the participants’ mood or condition. However, none of the participants expressed a desire to withdraw from the study. The dignity and autonomy of participants were always respected, and missing data were accepted when necessary. All available data were included in the analyses, even when some values were missing, as each analysis was conducted independently. For example, the analyses of the relationships (1) between FI and changes in cognitive function and (2) between cognitive function and ultrasonographic parameters at the second assessment were performed separately. This approach maximised the reliability of each analysis by utilising the full extent of the available data.

Statistical analyses

Statistical analyses were conducted using MATLAB software (MathWorks, Natick, MA, USA). The relationships among the three primary factors—FI, cognitive parameters (MMSE-J and FAB scores), and ultrasonographic parameters (DA, PSV, EDV, and RI)—were examined. The primary interest was whether these factors (e.g., FI × MMSE-Jc) are significantly corrected. To evaluate these associations, a non-parametric bootstrapping bootstrapping correlation analysis was employed, consistent with the finding of our previous study [18]. This approach offers methodological advantages over classical parametric inference methods, such as avoiding the assumption of Gaussian distributions [45]. For each variable pair, Spearman’s rank correlation coefficient (rho) was calculated by resampling the dataset with replacement across all participants 20,000 times using the ‘bootstrp’ function in MATLAB. The significance level (P-value) was defined as the smaller percentage of bootstrap samples in which the correlation coefficient was greater or less than zero. The grand mean of the correlation coefficient (rho) across bootstrap iterations and the corresponding P-values were reported. As the analysis produced a correlation matrix, in which each statistical value was tested against the null hypothesis (rho = 0), the results were susceptible to an increased risk of Type I error [46]. Therefore, the P-values were adjusted for the false discovery rate (FDR) using the Benjamini–Hochberg method [47]. These correlation analyses enabled the isolation of associations among the three factors, independent of external influences such as nursing care and environmental conditions. This implies that other factors were tested as noise in the correlation analyses; however, this does not preclude their potential contribution to cognitive improvement. Furthermore, control groups are not required in correlation analyses [48,49].

The analyses were structured into three parts, corresponding to the three primary factors examined in the study: FI, cognitive parameters, and ultrasonographic parameters. First, to test the main hypothesis (Theme 1 in Fig 1)—that an adequate amount of FI leads to cognitive improvement within an optimal range—the relationships between the mnFI and changes in cognitive parameters (MMSE-Jc and FABc) were investigated. These relationships were visualised using scatter plots, which revealed three participants exhibiting markedly different patterns (i.e., outliers) (Fig 2A). Consequently, their data were excluded from all subsequent statistical analyses. Following this visual inspection, the relationships between the mnFI and changes in cognitive parameters (MMSE-Jc and FABc) were examined using the non-parametric bootstrapping approach described earlier. Second, to explore the associations between FI and the four ultrasonographic parameters (Theme 2A in Fig 1), the same bootstrapping correlation analyses were applied. Third, to investigate the associations between cognitive state (i.e., MMSE-J and FAB scores) and the four ultrasonographic parameters (Theme 2B in Fig 1), three subsets of bootstrapping correlation analyses were conducted: one using data from the first assessment (e.g., MMSE-J1 × lDA1), another from the second assessments (e.g., MMSE-J2 × lDA12), and the third using the changes between assessments (e.g., MMSE-Jc × lDAc).

Fig 2. Correlations between the amount of fluid intake and changes in cognitive parameters.

Fig 2

The value shown in the corner of each plot represents the Spearman’s correlation coefficient (rho), averaged across bootstrap iterations; an asterisk (*) denotes a significant correlation. The filled dots indicate individual data points included in the statistical analysis, whereas circled dots denote outliers that were excluded. A least square regression line was included for significant correlations. Abbreviations: mnFI, amount of fluid intake normalised using lean body mass and averaged across the study period; MMSE-J, Japanese version of the Mini-Mental State Examination; FAB, Frontal Assessment Battery.

To provide an overview of the study context, comparisons of bodily profiles (body weight and LBM) and cognitive states (the MMSE-J and FAB scores) between the first and second assessments were conducted using non-parametric bootstrapping analyses.

Results

Overview of fluid intake, cognitive changes, and other profiles

The participant’s average body weight measurements were 49.5 ± 10.1 kg (N = 33; range: 33.0–68.6 kg) at the first bodily profile assessment and 49.3 ± 9.5 kg (N = 33; range: 34.4–66.6 kg) at the second assessment. No significant difference was observed at the group level (P = 0.384). The average LBM measurements were 35.0 ± 6.7 kg (N = 28, range: 26.0–48.3 kg) at the first bodily profile assessment and slightly decreased to 34.7 ± 7.4 kg (N = 25, range: 26.3–54.8 kg) at the second assessment, representing a significant reduction at the group level (P = 0.045). The mnFI was 33.8 ± 8.2 mL/LBM (kg) per day (N = 22; range: 14.4–48.5 mL/LBM (kg) per day). Given the average LBM of approximately 35 kg, this corresponds to an estimated daily FI of 1,200 mL, which is lower than values recommended in the facility (1,500 mL per day) and the EFSA guideline (1,600 mL per day for women and 2,000 mL per day for men) [12,24]. In terms of cognition, the MMSE-J scores were 18.4 ± 5.0 (N = 33; range 8–29) at the first assessment and 18.2 ± 5.7 (N = 32; range 8–28) at the second assessment. The FAB scores were 8.5 ± 3.6 (N = 32; range 0–14) at the first assessment and 8.7 ± 3.5 (N = 31; range 3–15) at the second assessment. Although no significant differences were observed between the first and second assessments at the group-level (P = 0.336 for MMSE-J; P = 0.362 for FAB), individual cognitive changes varied, with 12 out of 32 participants showing improvement in MMSE-J scores and 12 out of 30 participants showing improvement in FAB scores, while others experienced declines or no change. The following section examines whether the changes in cognition scores were associated with mnFI (Theme 1).

Associations between fluid intake and cognitive status (Theme 1)

Next, the relationships between the amount of FI (mnFI) and changes in cognitive status (Theme 1) were examined. Fig 2 presents scatter plots illustrating these relationships, which were visually inspected prior to detailed statistical analyses. For the MMSE-J (Fig 2A), a larger amount of FI was generally associated with greater improvement in MMSE-J scores, except for three participants whose mnFI exceeded 42 mL/LBM (kg) per day (ID0001:48.52, ID0002:47.43, and ID0030:44.82; Table 1). This threshold is hereafter referred to as the ‘critical amount’. Considering the average LBM of approximately 35 kg, the critical amount corresponds to roughly 1,500 mL per day. These three participants exhibited markedly decreased MMSE-J change scores (MMSE-Jc), consistent with our expectations (Fig 1B). Therefore, these participants were identified as outliers and excluded from all subsequent statistical analyses. Among the remaining participants, the mnFI was positively correlated with MMSE-Jc [N = 19, rho = 0.567, P(FDR) = 0.012]. For the FAB scores (Fig 2B), visual inspection revealed no linear association, which was confirmed by statistical analysis [N = 18, rho = 0.142, P(FDR) = 0.261].

Associations of fluid intake with ultrasonographic parameters (Theme 2A)

To explore the potential mechanisms underlying the association between increased FI and cognitive improvement, two sets of correlation analyses were performed. First, the correlations between the amount of FI (mnFI) and cerebral blood dynamics (i.e., ultrasonographic parameters) (Theme 2A in Fig 1) were investigated. The results indicated that the mnFI was positively correlated with change in the end-diastolic velocity in the right CCA (rEDVc) [N = 17 rho = 0.540, P(FDR) = 0.046] and negatively correlated with change in the resistance index measured at the right CCA (rRIc) [N = 17, rho = −0.537, P(FDR) = 0.046] (Fig 3 and Table 2). These findings suggest that increased FI was associated with elevated blood flow velocity during the end-diastolic phase and a reduction in vascular resistance. No significant correlations were found between mnFI and changes in other ultrasonographic parameters (Fig 3 and Table 2). Additionally, visual inspection of Fig 3 revealed that the three outliers (circled dots in Fig 3) exhibited patterns distinct from those of the other participants (filled dots in Fig 3) with respect to rEDVc and rRIc.

Fig 3. Correlations between the amount of fluid intake and changes in ultrasonographic parameters.

Fig 3

The correlations are shown for the (A) left and (B) right common carotid arteries. The number displayed in the corner of each plot indicates Spearman’s rank correlation coefficient (rho), averaged across bootstrap iterations; an asterisk (*) indicates significant correlation. Filled dots indicate the individual data points included in the statistical analysis, whereas circled dots indicate outliers excluded from the analysis. Least squares regression lines were added for significant correlations. Abbreviations: DA, diameter of the artery; PSV, peak systolic velocity; EDV, end-diastolic velocity; RI, resistance index; mnFI, amount of fluid intake normalised by lean body mass and averaged across the study period; CCA, common carotid artery.

Table 2. Correlations between fluid intake and ultrasonographic parameters.

DAc PSVc EDVc RIc
Left N 17 17 17 17
rho −0.141 0.067 0.443 −0.412
P(FDR) 0.395 0.395 0.110 0.110
Right N 17 17 17 17
rho −0.400 0.069 0.540 −0.537
P(FWE) 0.081 0.379 0.046* 0.046*

DA, diameter of the artery; PSV, peak systolic flow velocity; EDV, end-diastolic velocity; RI, resistance index; N, number of datasets used in the analysis; rho, Spearman’s rank correlation coefficient; P(FDR), P-value adjusted for the false discovery rate. An asterisk (*) indicates a significant correlation.

Associations of ultrasonographic parameters with cognitive state at the first and second assessments as well as their changes (Theme 2B)

Second, the associations between cerebral blood dynamics (i.e., ultrasonographic parameters) and cognitive state (i.e., MMSE-J and FAB scores) (Theme 2B in Fig 1) were examined separately at the first and second assessments as well as their changes. At the first assessment, no significant correlations were observed between any ultrasonographic parameters and either the MMSE-J or FAB scores (Table 3). At the second assessment, significant negative correlations were identified between the MMSE-J score and both the lRI2 [N = 27, rho = −0.483, P(FDR) = 0.032] and rRI2 [N = 27, rho = −0.485, P(FDR) = 0.020] (Fig 4 and Table 3). The FAB score was also negatively correlated with rRI2 [N = 26, rho = −0.440, P(FDR) = 0.040]. No other significant correlations were found. In terms of the changes in parameters, no correlations were observed between cognitive scores and any ultrasonographic parameters (Table 3). Visual inspection did not indicate any differential behaviour among the three previously identified outliers. In summary, these results suggest that better cognitive performance was associated with lower vascular resistance in the microcirculation, particularly when dehydration was not severe.

Table 3. Correlations between cognitive state and ultrasonographic parameters.

Left Right
DA PSV EDV RI DA PSV EDV RI
First assessment MMSE-J N 30 30 30 30 30 30 30 30
rho 0.059 0.038 0.316 −0.245 −0.074 −0.126 0.217 −0.365
P(FDR) 0.435 0.435 0.218 0.218 0.350 0.337 0.186 0.076
FAB N 29 29 29 29 29 0.50865 29 29
rho −0.161 0.149 0.289 −0.216 −0.150 −0.029 0.195 −0.219
P(FDR) 0.230 0.230 0.230 0.230 0.313 0.438 0.266 0.266
Second assessment MMSE-J N 27 27 27 27 27 27 27 27
rho −0.014 −0.143 0.326 −0.483 −0.151 −0.178 0.340 −0.485
P(FDR) 0.478 0.333 0.126 0.032* 0.241 0.219 0.076 0.020*
FAB N 26 26 26 26 26 26 26 26
rho 0.090 −0.145 0.178 −0.337 0.020 −0.171 0.261 −0.440
P(FWE) 0.332 0.332 0.332 0.164 0.457 0.276 0.170 0.040*
Change MMSE-J N 27 27 27 27 27 27 27 27
rho −0.130 −0.226 −0.236 0.034 −0.094 −0.322 −0.112 −0.053
P(FWE) 0.303 0.246 0.246 0.436 0.399 0.200 0.399 0.399
FAB N 25 25 25 25 25 25 25 25
rho −0.065 0.316 0.112 0.167 0.013 0.243 0.278 0.015
P(FWE) 0.375 0.292 0.375 0.364 0.477 0.288 0.220 0.477

DA, diameter of artery; PSV, peak systolic flow velocity; EDV, end-diastolic velocity; RI, resistance index; MMSE-J, Mini-Mental State Examination; FAB, Frontal Assessment Battery; N, number of datasets used in the analysis; rho, Sperman’s linear correlation coefficient; P(FDR), P-value adjusted for the false discovery rate. An asterisk (*) indicates significant correlation.

Fig 4. Correlations between cognitive state and ultrasonographic parameters at the second assessment.

Fig 4

The number displayed at the corner of each plot indicates Spearman’s correlation coefficient (rho) averaged across bootstrap iterations. Filled dots indicate the individual data considered for statistical analysis, whereas circled dots indicate the outliers excluded from the analysis. Least square regression lines were added for significant correlations. Abbreviations: MMSE-J, Japanese version of the Mini-Mental State Examination; FAB, Frontal Assessment Battery; DA, diameter of the artery; PSV, peak systolic velocity; EDV, end-diastolic velocity; RI, resistance index; CCA, common carotid artery.

Discussion

Two principal findings emerged from the present study. First (Theme 1), a large amount of FI (mnFI) was linearly correlated with cognitive improvement, as indicated by changes in the MMSE-J score (MMSE-Jc) when the intake remained below the critical threshold of 42 mL per kg of lean body mass per day (Fig 2). Second (Theme 2), the daily amount of FI (mnFI) was significantly associated with changes in cerebral blood dynamics, as assessed by ultrasonographic parameters (Fig 3).

Dehydration is a common health issue among older adults [20] and impairs cognitive performance [12,1620,22,23]. It alters cerebral microcirculation [16,50], hormonal levels (e.g., cortisol, serotonin, and dopamine) [51], cell metabolism [52,53], and synaptic structure and function [16], all of which contribute to cognitive decline [17,18]. However, the importance of maintaining adequate hydration for cognitive health has been largely overlooked, and only a limited number of studies have addressed this topic [12,19,21,53]. Notably, the World Health Organization’s guidelines for preventing dementia have not yet mentioned fluid intake as a consideration [9]. To promote FI among older individuals as a means to support cognitive function, robust evidence is needed to demonstrate that adequate hydration improves cognition (Theme 1 in Fig 1) and to understand the potential underlying mechanisms (Theme 2 in Fig 1). To address these two research themes, three correlation analyses were conducted: (1) between FI and changes in cognitive state (Theme 1 in Fig 1), (2) between FI and ultrasonographic parameters (Theme 2A in Fig 1), and (3) between changes in cognitive state and ultrasonographic parameters (Theme 2B in Fig 1). Each analysis is discussed in detail below.

Relationship between FI and change in cognitive state (Theme 1)

To address the first theme (Fig 1), the relationship between FI and changes in the cognitive state was initially examined through visual inspection of scatter plots (Fig 2) followed by statistical analyses.

A significant positive correlation was observed between mnFI and changes in MMSE-J scores (MMSE-Jc), when the mnFI remained below the critical threshold of 42 mL/LBM (kg) per day. The significant correlation was confirmed through statistical analysis [P(FDR) = 0.012]. An adequate amount of FI is likely sufficient to mitigate the participants’ dehydration status, resulting in the observed cognitive changes (Fig 1C), given that a substantial proportion of older adults experience dehydration that remains undetected [20,23]. Furthermore, the absence of improvement in MMSE-J scores with excessive FI can be intuitively explained by the inverted U-shaped curve presented in Fig 2A, which resembles the relationship between cardiac output and preload (i.e., blood volume) in patients with heart failure [31] (Fig 1B). With regard to the FAB score, no linear association was identified between the amount of FI and FABc, as confirmed by statistical analysis [P(FDR) = 0.261]. Based on these findings, the amount of FI correlates positively with changes in the cognitive state with two limitations: (1) the linear association applies only within a specific range of FI, and (2) only certain cognitive domains (i.e., MMSE-J, not FAB) show a correlation with FI. When encouraging older adults to increase FI to improve cognition, these potential limitations must be considered. The critical FI for the participants was identified as 42 mL/LBM (kg) per day. Given an average LBM of approximately 35 kg, the average FI was approximately 1,500 mL per day, which aligns with the facility’s recommended amount (1,500 mL per day) and falls slightly below the EFSA guidelines (1,600 mL per day for women and 2,000 mL per day for men) [12,24]. The critical FI may vary among different groups of older adults and can fall below the recommended levels. Outliers with FI exceeding the critical threshold will be addressed again at the end of the Discussion section. Subsequent analyses concentrated on participants whose mnFI fell below the critical value of 42 mL per kg of LBM per day; three outliers were excluded from further consideration.

Potential mechanisms linking FI to changes in cerebral blood dynamics (Theme 2A)

The second theme of the present study addresses the potential mechanisms underlying the relationship between increased FI and cognitive improvement (Fig 1). We hypothesised that adequate FI would alleviate dehydration, improve cerebral blood dynamics, and lead to cognitive improvement (Blue boxes in Fig 1). To test the hypothesis, ultrasonography was employed to provide information on cerebral blood dynamics. To address Theme 2, two sets of correlation analyses were conducted: (1) between FI and changes in ultrasonographic parameters (Theme 2A in Fig 1) and (2) between cognitive state and ultrasonographic parameters (Theme 2B in Fig 1). In the first set of correlations, the mnFI was correlated with the rEDVc and rRIc (Fig 3 and Table 2). The RI represents haemodynamic resistance, primarily influenced by the distal cerebral microvascular bed [54,55]. Increased mnFI is plausibly associated with dilation of the cerebral microvessels, leading to a reduction in RI. The positive correlation observed between mnFI and EDV can be explained by the inverse relationship between RI and EDV as defined by RI = (PSV − EDV)/ PSV. A previous study has demonstrated that lower EDV predicts adverse health events, such as ischaemic attacks or ischaemic stroke [5658]. Consequently, higher EDV reflects a healthier cerebral condition, which aligns with the finding that increased mnFI is associated with higher EDV and improved cognition. In summary, these results support the hypothesis that an adequate amount of FI (mnFI) improves cerebral blood dynamics (Theme 2A) predominantly within the cerebral microcirculation.

Potential mechanisms linking cerebral blood dynamics to cognitive function (Theme 2B)

To confirm that cerebral blood dynamics are associated with cognitive state (Theme 2B), a second set of correlation analyses was conducted. This analysis comprised three subgroups: values obtained during the first assessment, the second assessment, and the changes between the two. The first assessment was conducted within two weeks of admission (6.1 ± 5.0 days). During this period, participants were likely affected by varying levels of dehydration, as their physical condition may have been influenced by their pre-admission lifestyles. Community-dwelling older individuals are particularly prone to dehydration (Fig 1A) [20]. Under these conditions, no significant correlation was found between ultrasonographic parameters and cognitive state (Table 3). This absence of association may be attributed to inter-individual variability in dehydration levels, which likely introduced random variances into cerebral blood dynamics and thereby weakened group-level correlations. The second assessment was conducted several months after admission (82.6 ± 14.9 days). By this time, the likelihood of dehydration had decreased, as participants had been consistently encouraged to increase their FI, with a target of 1,500 L per day (Fig 1A). Under these more stabilised conditions, MMSE-J2 scores were negatively correlated with both lRI2 and rRI2 (Fig 4 and Table 3). As previously discussed, the RI reflects resistance within the cerebral microvasculature [54,55], with higher indicating poorer microcirculatory function. These findings suggest that cognitive impairment can be partially explained by suboptimal microvascular cerebral blood flow. Cerebral blood flow is affected by hydration status [16,50], which is in turn is affected by FI. Taken together, the MMSE-J score is dependent on the condition of the cerebral microvasculature and that adequate FI contributes to cognitive improvement through enhanced microcirculatory dynamics. The FAB score was also associated with rRI2. However, no significant correlation was found between mnFI and changes in FAB scores (Fig 2B). This suggests that although the FAB score may also be influenced by cerebral microcirculation, the relationship appears to be weaker than that observed for the MMSE-J.

In the third subgroups of correlation analyses (examining the relationship between changes in ultrasonographic parameters and changes in cognitive state), no significant correlations were observed with either the MMSE-Jc or FABc scores (Table 3). These negative findings may be attributed to the absence of associations during the first assessment, likely resulting from substantial inter-individual variability in dehydration status at baseline.

Three outliers in Fig 2

In Fig 2, three of the 22 participants exhibited divergent patterns, having consumed fluid exceeding the critical threshold [42 mL/LBM (kg) per day]. These individuals were excluded from the statistical analyses. Despite their high FI, no improvement in MMSE-J scores was observed, contrary to expectations based on fluid intake alone. Their behaviour differed from that of the others in Fig 3 (rEDVc and rRIc), whereas a similar pattern was observed in Fig 4. This suggests that the relationship between FI and cerebral blood dynamics was disrupted, whereas the relationship between cerebral blood dynamics and cognition was preserved. This finding aligns with our expectation that excessive FI may exert an adverse effect on cardiac output, thereby negatively impacting cognitive function.

Limitations

The current study has some limitations. First, it was an observational study, dependent on a clinical dataset recorded for care purposes. Some datasets exhibited missing values, and some minor date mismatches were observed (Table 1). However, these issues had a negligible influence on the findings, as missing data were appropriately addressed in the statistical analyses, and the study period substantially exceeded the short intervals affected by date mismatches. Additionally, causal relationships between cognitive changes and the other two factors—namely, FI and ultrasonographic parameters—could not be established, as is inherent in observational research. Second, this study was conducted at a single geriatric health service facility. Caution is therefore warranted in generalising the findings, particularly with regard to the critical FI threshold of 42 mL per kg of LBM per day, which may vary among different populations of older adults. Third, FI was not measured prior to admission, and the severity of dehydration at the time of enrollment could not be estimated. As this study was conducted in a geriatric health service facility setting, laboratory measurements such as plasma osmolality were unavailable. However, the severity of dehydration was assumed to be randomly distributed among participants, and the applied statistical methods are believed to have minimised its potential influence. The results presented here are based on statistical analyses and are reliable within the acceptable standards of scientific reporting based on P-values. Hence, future interventional studies should address the second and third limitations identified.

Conclusion

Daily FI was found to influence cerebral microcirculation, leading to improvements in certain aspects of cognitive function. These results underscore the clinical significance of managing hydration status to support optimal cognitive performance, with consideration given to cerebral blood dynamics.

Acknowledgments

We extend our deepest gratitude to the participants of this study. We would also like to express our sincere respect for their invaluable contributions to the invaluable contributions of medical science. We sincerely appreciate Dr. Hajime Kamada (Honorary chairperson, Hokuto Hospital) and Dr. Shigeru Kitamori (Chairperson, Geriatric Health Services Facility, Kakehashi) for providing access to these facilities. We appreciate the contributions and support of nurses, therapists, care workers, and all other staff in Kakehashi. We would also like to thank Editage (www.editage.com) for providing English language editing assistance.

Data Availability

All data generated or analysed in this study are openly available in Mendeley Data at Shigihara, Yoshihito (2024), “Fluid intake and cognition”, Mendeley Data, V1, doi: 10.17632/pbj9vcwhfg.1.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Gela YY, Fekadu SA, Belsti Y, Akalu Y, Dagnew B, Getnet M, et al. Cognitive impairment and associated factors among mature and older adults living in the community of Gondar town, Ethiopia, 2020. Sci Rep. 2022;12:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bárrios H, Narciso S, Guerreiro M, Maroco J, Logsdon R, de Mendonça A. Quality of life in patients with mild cognitive impairment. Aging Ment Health. 2013;17(3):287–92. doi: 10.1080/13607863.2012.747083 [DOI] [PubMed] [Google Scholar]
  • 3.Gauthier S, Rosa-Neto P, Morais J, Webster C. World Alzheimer Report 2021: Journey through the diagnosis of dementia. London. 2021. [Google Scholar]
  • 4.Wang Y, Haaksma ML, Ramakers IHGB, Verhey FRJ, van de Flier WM, Scheltens P, et al. Cognitive and functional progression of dementia in two longitudinal studies. Int J Geriatr Psychiatry. 2019;34(11):1623–32. doi: 10.1002/gps.5175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hirakawa A, Sato H, Hanazawa R, Suzuki K, Japanese Alzheimer’s Disease Neuroimaging Initiative. Estimating the longitudinal trajectory of cognitive function measurement using short-term data with different disease stages: Application in Alzheimer’s disease. Stat Med. 2022;41(21):4200–14. doi: 10.1002/sim.9504 [DOI] [PubMed] [Google Scholar]
  • 6.Mathews SB, Arnold SE, Epperson CN. Hospitalization and cognitive decline: Can the nature of the relationship be deciphered?. Am J Geriatr Psychiatry. 2014;22(5):465–80. doi: 10.1016/j.jagp.2012.08.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Shigihara Y, Hoshi H, Shinada K, Okada T, Kamada H. Non-pharmacological treatment changes brain activity in patients with dementia. Sci Rep. 2020;10(1):6744. doi: 10.1038/s41598-020-63881-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–734. doi: 10.1016/S0140-6736(17)31363-6 [DOI] [PubMed] [Google Scholar]
  • 9.WHO. Risk reduction of cognitive decline and dementia: WHO guidelines. 96. 2019. [PubMed]
  • 10.Iacono D, Markesbery WR, Gross M, Pletnikova O, Rudow G, Zandi P, et al. The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology. 2009;73(9):665–73. doi: 10.1212/WNL.0b013e3181b01077 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mintzer J, Donovan KA, Kindy AZ, Lock SL, Chura LR, Barracca N. Lifestyle Choices and Brain Health. Front Med (Lausanne). 2019;6:204. doi: 10.3389/fmed.2019.00204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Li S, Xiao X, Zhang X. Hydration Status in Older Adults: Current Knowledge and Future Challenges. Nutrients. 2023;15(11):2609. doi: 10.3390/nu15112609 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wang B, Wei X, Zhao X, Wang W, Deng J, Yang H. A Review on In Vivo Research Dehydration Models and Application of Rehydration Strategies. Nutrients. 2024;16(20):3566. doi: 10.3390/nu16203566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zhang N, Du SM, Zhang JF, Ma GS. Effects of Dehydration and Rehydration on Cognitive Performance and Mood among Male College Students in Cangzhou, China: A Self-Controlled Trial. Int J Environ Res Public Health. 2019;16(11):1891. doi: 10.3390/ijerph16111891 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Puga AM, Lopez-Oliva S, Trives C, Partearroyo T, Varela-Moreiras G. Effects of Drugs and Excipients on Hydration Status. Nutrients. 2019;11(3):669. doi: 10.3390/nu11030669 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Lauriola M, Mangiacotti A, D’Onofrio G, Cascavilla L, Paris F, Paroni G, et al. Neurocognitive Disorders and Dehydration in Older Patients: Clinical Experience Supports the Hydromolecular Hypothesis of Dementia. Nutrients. 2018;10(5):562. doi: 10.3390/nu10050562 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Leeuwis AE, Smith LA, Melbourne A, Hughes AD, Richards M, Prins ND, et al. Cerebral Blood Flow and Cognitive Functioning in a Community-Based, Multi-Ethnic Cohort: The SABRE Study. Front Aging Neurosci. 2018;10:279. doi: 10.3389/fnagi.2018.00279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Matsumoto T, Hoshi H, Hirata Y, Ichikawa S, Fukasawa K, Gonda T, et al. The association between carotid blood flow and resting-state brain activity in patients with cerebrovascular diseases. Sci Rep. 2021;11(1):15225. doi: 10.1038/s41598-021-94717-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Nishi SK, Babio N, Paz-Graniel I, Serra-Majem L, Vioque J, Fitó M, et al. Water intake, hydration status and 2-year changes in cognitive performance: a prospective cohort study. BMC Med. 2023;21(1):82. doi: 10.1186/s12916-023-02771-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Stookey JD, Pieper CF, Cohen HJ. Is the prevalence of dehydration among community-dwelling older adults really low? Informing current debate over the fluid recommendation for adults aged 70+years. Public Health Nutr. 2005;8(8):1275–85. doi: 10.1079/phn2005829 [DOI] [PubMed] [Google Scholar]
  • 21.Kleiner SM. Water: an essential but overlooked nutrient. J Am Diet Assoc. 1999;99(2):200–6. doi: 10.1016/S0002-8223(99)00048-6 [DOI] [PubMed] [Google Scholar]
  • 22.Miller HJ. Dehydration in the Older Adult. J Gerontol Nurs. 2015;41(9):8–13. doi: 10.3928/00989134-20150814-02 [DOI] [PubMed] [Google Scholar]
  • 23.Mentes JC. A typology of oral hydration problems exhibited by frail nursing home residents. J Gerontol Nurs. 2006;32(1):13–9; quiz 20–1. doi: 10.3928/0098-9134-20060101-09 [DOI] [PubMed] [Google Scholar]
  • 24.EFSA Panel on Dietetic Products Nutrition and Allergic (NDA). Scientific opinion on dietary reference values for water. EFSA Journal. 2010;8. [Google Scholar]
  • 25.Díez-Villanueva P, Jiménez-Méndez C, Alfonso F. Heart failure in the elderly. J Geriatr Cardiol. 2021;18(3):219–32. doi: 10.11909/j.issn.1671-5411.2021.03.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Danielsen R, Thorgeirsson G, Einarsson H, Ólafsson Ö, Aspelund T, Harris TB, et al. Prevalence of heart failure in the elderly and future projections: the AGES-Reykjavík study. Scand Cardiovasc J. 2017;51(4):183–9. doi: 10.1080/14017431.2017.1311023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Montalto M, D’Ignazio F, Camilli S, Di Francesco S, Fedele M, Landi F, et al. Heart Failure in Older Patients: An Update. J Clin Med. 2025;14(6):1982. doi: 10.3390/jcm14061982 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hsu S-M, Lin Y-H, Lin Y-C, Liu S-J, Liu C-J, Hung C-L, et al. Fluid intake impact on heart failure: Systematic review and meta-analysis with trial sequential analysis. J Formos Med Assoc. 2025;124(7):650–9. doi: 10.1016/j.jfma.2024.11.017 [DOI] [PubMed] [Google Scholar]
  • 29.Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–1032. doi: 10.1161/CIR.0000000000001063 [DOI] [PubMed] [Google Scholar]
  • 30.McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726. doi: 10.1093/eurheartj/ehab368 [DOI] [PubMed] [Google Scholar]
  • 31.Sahni M, Asrani P, Jain SK. Role of the renin-angiotensin-aldosterone system in the management of neonatal heart failure. Neoreviews. 2015;16:e575-585. [Google Scholar]
  • 32.Kleaveland JP, Kussmaul WG, Vinciguerra T, Diters R, Carabello BA. Volume overload hypertrophy in a closed-chest model of mitral regurgitation. Am J Physiol. 1988;254(6 Pt 2):H1034-41. doi: 10.1152/ajpheart.1988.254.6.H1034 [DOI] [PubMed] [Google Scholar]
  • 33.Wang X, Ren B, Liu S, Sentex E, Tappia PS, Dhalla NS. Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. J Appl Physiol (1985). 2003;94(2):752–63. doi: 10.1152/japplphysiol.00248.2002 [DOI] [PubMed] [Google Scholar]
  • 34.Duschek S, Schandry R. Reduced brain perfusion and cognitive performance due to constitutional hypotension. Clin Auton Res. 2007;17(2):69–76. doi: 10.1007/s10286-006-0379-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.van Dinther M, Hooghiemstra AM, Bron EE, Versteeg A, Leeuwis AE, Kalay T, et al. Lower cerebral blood flow predicts cognitive decline in patients with vascular cognitive impairment. Alzheimers Dement. 2024;20(1):136–44. doi: 10.1002/alz.13408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Leeuwis AE, Benedictus MR, Kuijer JPA, Binnewijzend MAA, Hooghiemstra AM, Verfaillie SCJ, et al. Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer’s disease. Alzheimers Dement. 2017;13(5):531–40. doi: 10.1016/j.jalz.2016.08.013 [DOI] [PubMed] [Google Scholar]
  • 37.Wang Z, Deurenberg P, Wang W, Pietrobelli A, Baumgartner RN, Heymsfield SB. Hydration of fat-free body mass: new physiological modeling approach. Am J Physiol. 1999;276(6):E995–1003. doi: 10.1152/ajpendo.1999.276.6.E995 [DOI] [PubMed] [Google Scholar]
  • 38.Sawka MN, Cheuvront SN, Carter R. Human Water Needs. Nutr Rev. 2005;63:S30-39. [DOI] [PubMed] [Google Scholar]
  • 39.Armstrong LE. Assessing hydration status: the elusive gold standard. J Am Coll Nutr. 2007;26(5 Suppl):575S-584S. doi: 10.1080/07315724.2007.10719661 [DOI] [PubMed] [Google Scholar]
  • 40.Sugishita M, Hemmi I, Iwatsubo T. Japanese versions equivalent to original English neuropsychological tests in ADNI. Alzheimer’s & Dementia. 2010;6:S348. [Google Scholar]
  • 41.Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621–6. doi: 10.1212/wnl.55.11.1621 [DOI] [PubMed] [Google Scholar]
  • 42.Shigemori K, Ohgi S, Okuyama E, Shimura T, Schneider E. The factorial structure of the Mini-Mental State Examination (MMSE) in Japanese dementia patients. BMC Geriatr. 2010;10:36. doi: 10.1186/1471-2318-10-36 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Dinomais M, Celle S, Duval GT, Roche F, Henni S, Bartha R, et al. Anatomic Correlation of the Mini-Mental State Examination: A Voxel-Based Morphometric Study in Older Adults. PLoS One. 2016;11(10):e0162889. doi: 10.1371/journal.pone.0162889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Bak TH, Mioshi E. A cognitive bedside assessment beyond the MMSE: the Addenbrooke’s Cognitive Examination. Pract Neurol. 2007;7(4):245–9. [PubMed] [Google Scholar]
  • 45.Wasserman S, Bockenholt U. Bootstrapping: applications to psychophysiology. Psychophysiology. 1989;26:208–21. [DOI] [PubMed] [Google Scholar]
  • 46.Curran-Everett D. Multiple comparisons: philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol. 2000;279(1):R1-8. doi: 10.1152/ajpregu.2000.279.1.R1 [DOI] [PubMed] [Google Scholar]
  • 47.Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289–300. [Google Scholar]
  • 48.Price PC, Jhangiani R, Chiang ICA. Correlational research – research methods in psychology – 2nd Canadian edition. 2nd ed. Opentextbc.Ca: BCcampus. 2020. [Google Scholar]
  • 49.Lau F, Kuziemsky C. Handbook of eHealth evaluation: an evidence-based approach. University of Victoria. 2017. [PubMed] [Google Scholar]
  • 50.Trangmar SJ, Chiesa ST, Llodio I, Garcia B, Kalsi KK, Secher NH, et al. Dehydration accelerates reductions in cerebral blood flow during prolonged exercise in the heat without compromising brain metabolism. Am J Physiol Heart Circ Physiol. 2015;309(9):H1598-607. doi: 10.1152/ajpheart.00525.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Masento NA, Golightly M, Field DT, Butler LT, van Reekum CM. Effects of hydration status on cognitive performance and mood. Br J Nutr. 2014;111(10):1841–52. doi: 10.1017/S0007114513004455 [DOI] [PubMed] [Google Scholar]
  • 52.Chumlea WC, Guo SS, Zeller CM, Reo NV, Siervogel RM. Total body water data for white adults 18 to 64 years of age: the Fels Longitudinal Study. Kidney Int. 1999;56(1):244–52. doi: 10.1046/j.1523-1755.1999.00532.x [DOI] [PubMed] [Google Scholar]
  • 53.Ritz P, Vol S, Berrut G, Tack I, Arnaud MJ, Tichet J. Influence of gender and body composition on hydration and body water spaces. Clin Nutr. 2008;27(5):740–6. doi: 10.1016/j.clnu.2008.07.010 [DOI] [PubMed] [Google Scholar]
  • 54.Oglat AA, Matjafri MZ, Suardi N, Oqlat MA, Abdelrahman MA, Oqlat AA. A Review of Medical Doppler Ultrasonography of Blood Flow in General and Especially in Common Carotid Artery. J Med Ultrasound. 2018;26(1):3–13. doi: 10.4103/JMU.JMU_11_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Morillas P, Quiles J, Mateo I, Bertomeu-González V, Castillo J, de Andrade H, et al. Carotid resistive index in treated hypertensive patients: relationship with target organ damage. Blood Press. 2012;21(6):360–6. doi: 10.3109/08037051.2012.694181 [DOI] [PubMed] [Google Scholar]
  • 56.Chung H, Jung YH, Kim K-H, Kim J-Y, Min P-K, Yoon YW, et al. Carotid Artery End-Diastolic Velocity and Future Cerebro-Cardiovascular Events in Asymptomatic High Risk Patients. Korean Circ J. 2016;46(1):72–8. doi: 10.4070/kcj.2016.46.1.72 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Dilic M, Kulic M, Balic S, Dzubur A, Hadzimehmedagic A, Vranic H, et al. Cerebrovascular events: correlation with plaque type, velocity parameters and multiple risk factors. Med Arh. 2010;64(4):204–7. [PubMed] [Google Scholar]
  • 58.Ghorbani A, Ashtari F, Fatehi F. The assessment value of transcranial Doppler sonography versus magnetic resonance angiography in vertebrobasilar stroke. J Res Med Sci. 2010;15(3):133–9. [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Tanja Grubić Kezele

15 Apr 2025

PONE-D-25-10914Fluid intake modifies cognitive status in older individuals: a prospective studyPLOS ONE

Dear Dr. Shigihara,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Based on the reviewers' suggestions, the paper needs major revision. The reviewers' comments can be found below.

Please submit your revised manuscript by May 30 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Tanja Grubić Kezele, Ph.D., M.D.

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Competing Interests section: [YS is leading a joint research project with RICOH Co., Ltd. and Itoen Co., Ltd. HH was employed by RICOH Co., Ltd. YK, EM, and KS declare no potential conflict of interest.].

We note that you received funding from a commercial source: [RICOH Co., Ltd]

Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc.

Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I commend the authors for their hard work and dedication to the implementation of this study. Please see comments below on suggestions for improving your manuscript.

Abstract

The abstract is lengthy but is lacking in key aspects. Primarily of concern, there is no actual data given for results. This is of absolute importance and the key statistical analyses and numerically reported outcomes must be presented.

Introduction

The second and third sentence begin with the word "It". Be more direct in your writing style.

Line 62: Should be no y after thirst.

You need to develop a proper problem statement.

Line 66: Your hypothesis statement occurs before your purpose statement.

Methods

My main concern is the design of the study.

It is never explicitly stated how fluid intake was measured. For example, did patients drink out of metered containers and the change in mass or volume was assessed?

You have a within subjects design, but there seems to be no true control and intervention arm. First assessment was taken between 0-16 days after admission. Then, a second assessment occurred approximately 83 days later. The induction of blinded, reduced or increased fluid intake after a few weeks of hospitalization would have been a much stronger design. The ultrasonographic score changes with reduced or increased FI could have been confirmed, and then you could even have simply tested cognition during periods of lower and higher cererbral blood flow dynamics parameters.

No background or explanation of the cognitive status questionnaires is given.

Number of participants: There are so many missing pieces of data it is difficult to follow the paper. All participants with missing data need to be removed. The abstract makes it appear that the n is almost double of the participants applicable in one of your most important figure (i.e. Figure 1) when the 3 outliers were removed. I am also not convinced the rationale for removing this data is valid.

No validation for the instrument used for determining BFP is provided. Did you see high variance in the patients? I may have overlooked where this outcome's data are located, but if no, why not just base relative fluid intake off body mass?

There is just an overload of tables and figures. It is difficult to follow.

Reviewer #2: Shigihara et al. conducted a study involving 33 Japanese elderly people. The aim of the study was to evaluate the associations between fluids intake and cognitive performances. More specifically, they assessed cerebral blood dynamics. The authors concluded that elderly people with higher fluid intake showed more improvements in their cognition, which is based on the changes in cerebral blood dynamics. Cerebral blood dynamics can be used to monitor patients’ dehydration states, which affect their cognitive status.

Major comments.

The sample size is only 33 individuals, and they are all from a single geriatric health service facility. The sample has a high degree of homogeneity, which may lack broad representativeness. As a result, it is difficult to extrapolate the research findings to a more general elderly population. It is recommended that in future studies, the sample size be expanded and elderly people from different regions and with diverse life backgrounds be included. Furthermore, It is impossible to assess the patients' fluid intake and dehydration status before admission, which may lead to biases in the research results. Although fluid intake was recorded during the study period, the situation before admission is unknown, which may interfere with the judgment of the relationship between fluid intake and cognition.

Followed are the details.

1.     Abstract: The characteristics of the survey subjects is not well defined. It is unknown whether they are healthy, and if they have chronic diseases. During the research process, it is unclear how many subjects withdrew, and for what reasons. Also, the average age of the subjects and the duration of the study are not provided. The authors just showed the “several months”, three months? Six months? Please clarify.

2.The study lack of Control Group: This study lacks a control group, making it difficult to determine that changes in cognitive status are solely due to fluid intake. For example, during the intervention period, factors such as changes in nursing methods and living environment may also affect cognitive status, but it is impossible to distinguish their effects from those of fluid intake in this study. It is recommended to add a control group in future research, such as setting parallel groups with different fluid intake standards, or comparing two groups of elderly people receiving regular care and enhanced fluid intake care, so as to more accurately assess the impact of fluid intake on cognitive status.

3.As for the methods measuring the cognitive performances, the MMSE-J and FAB were used to assess cognitive status, which may not fully reflect all aspects of cognitive function. Aspects such as executive function and other different dimensions of memory were not fully covered in this study. As shown in previous studies, the Short-term memory and attention are the most vulnerable to the effects of dehydration. But in this study, the aspects of the cognitive performances were not assessed. Moreover, when assessing brain activity, relying solely on several parameters measured by carotid ultrasound is difficult to comprehensively reflect the complex hemodynamic changes in the brain. Techniques such as functional magnetic resonance imaging (fMRI) and transcranial Doppler ultrasound (TCD) can be considered to obtain richer brain hemodynamic data.

4.Statistical Analysis: The characteristics of the elderly people was not displayed in this part, such as the gender, age, height, weight, and if they were healthy or had some chronic diseases. I recommend the authors to add the information. When dealing with multivariate relationships, using only Pearson correlation analysis and bootstrapping methods is somewhat insufficient. In the case of multiple confounding factors such as age and underlying diseases, multiple linear regression analysis should be considered to clarify the independent contributions of various factors to changes in cognitive status. Data Normality Test: The article does not mention conducting normality tests on the data, and some statistical methods (such as Pearson correlation analysis) have certain requirements for data distribution. If the data do not meet the normality assumption, it may lead to biases in statistical results. It is recommended to supplement data normality tests and select appropriate statistical methods according to the data distribution, such as non - parametric tests.

5.Results Section: In the "Results" section, the description of some key results is not detailed enough. For example, when referring to the improvement of participants' cognitive status, it only states that "More than one - third of the participants showed an increase in MMSE-J scores after the study period", without specifying the specific proportion and number of people, which is not conducive to readers' accurate understanding of the results. Specific proportion and number information should be supplemented to enhance the persuasiveness of the results. When describing the relationship between ultrasonic parameters and cognitive status, only correlation coefficients and P - values are listed, lacking an explanation of the practical significance. For example, when stating that MMSE-J2 is negatively correlated with lPI2, lRI2, and rRI2, it should be further explained what this negative correlation means clinically and how it actually affects the cognitive function of the elderly.

6.References: The number of references in this article is too small, and there are only seven references from the past five years (7/34). It is recommended that the author conduct a new literature review.

This article needs to be revised. I do not recommend its publication.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewers comments.doc

pone.0333793.s001.doc (32.5KB, doc)
PLoS One. 2025 Oct 6;20(10):e0333793. doi: 10.1371/journal.pone.0333793.r002

Author response to Decision Letter 1


2 Jun 2025

Response to reviewers:

To the editor and reviewers:

Thank you for the opportunity to submit a revised version of our manuscript entitled ‘Effect of fluid intake on cognitive function in older individuals: A prospective study’.

We appreciate the time and effort you have invested in reviewing our manuscript. Your insightful comments and constructive feedback have been invaluable in enhancing the quality and clarity of our study. We have carefully revised the manuscript to address all of your suggestions and concerns. We displayed all changes in blue font instead of using the Track Changes function in MS Word, as there were too many edits in the 'Revised Manuscript with Track Changes.docx' file.

Please find below our point-by-point responses to each of the comments.

Response to Reviewer 1 Comments

Comment 1-1.

Abstract

The abstract is lengthy but is lacking in key aspects. Primarily of concern, there is no actual data given for results. This is of absolute importance and the key statistical analyses and numerically reported outcomes must be presented.

Response 1-1:

Thank you for your insightful comment. We have revised the Abstract to include specific figures, such as P-values to enhance clarity and precision. We hope the revised abstract addresses the reviewer’s concern satisfactorily.

Comment 1-2.

Introduction

The second and third sentence begin with the word "It". Be more direct in your writing style.

Response 1-2:

Thank you for your valuable suggestion. In accordance with the suggestion, we have revised the sentence (lines 43–45 in the revised manuscript). In addition, the manuscript has been edited by the same professional English editing service as in the previous version. We hope the revised text now reads more naturally.

Comment 1-3.

Line 62: Should be no y after thirst.

Response 1-3:

Thank you for your suggestion. We have removed the letter ‘y’ in the revised manuscript (line 53 in the revised manuscript).

Comment 1-4.

You need to develop a proper problem statement.

Response 1-4:

Thank you for your valuable feedback. This comment made us realise that the original introduction lacked clarity and consideration. In response, we re-organised the latter half of the introduction and added a new Fig 1 to accurately convey the study concept and hypothesis. Additionally, we revised the entire Discussion section to ensure consistency with the updated introduction. We appreciate the opportunity to improve the manuscript.

Comment 1-5.

Line 66: Your hypothesis statement occurs before your purpose statement.

Response 1-5:

Thank you for your valuable comment. In accordance with your suggestion, we have completely re-organised the latter half of the Introduction section. We hope that the revised version meets the reviewer’s expectations.

Comment 1-6.

Methods

My main concern is the design of the study.

It is never explicitly stated how fluid intake was measured. For example, did patients drink out of metered containers and the change in mass or volume was assessed?

Response 1-6:

Thank you for your valuable comment. We apologize for not explicitly highlighting this aspect in the previous manuscript, despite its central importance to the study. In response to your feedback, we have revised the manuscript in lines 137 to 142 to address this point.

As a clinical recommendation within the facility, all older residents were advised to maintain a fluid intake of approximately 1,500 mL per day. Staff members, including nurses, therapists, and care workers provided fluids such as water or green tea in cups marked with a scale, both at the bedside and in the refectories during meals and upon request. The amount of fluid consumed was documented in the residents’ clinical records as a part of routine clinical practice. We have referenced these clinical records in our study.

Comment 1-7.

You have a within subjects design, but there seems to be no true control and intervention arm. First assessment was taken between 0-16 days after admission. Then, a second assessment occurred approximately 83 days later. The induction of blinded, reduced or increased fluid intake after a few weeks of hospitalization would have been a much stronger design. The ultrasonographic score changes with reduced or increased FI could have been confirmed, and then you could even have simply tested cognition during periods of lower and higher cererbral blood flow dynamics parameters.

Response 1-7:

Thank you for your insightful comment regarding our study design. We apologize for the insufficient description in the previous version. In accordance with your suggestion, we added a new Fig 1 that illustrates the study concept and protocol at a glance. We hope this addition adequately addresses your concerns.

One of the primary objectives of the current study is to examine the relationship between fluid intake and changes in cognitive state (Theme 1 in Fig 1). The analyses are based on correlation analyses and do not require a control group (lines 240–241 in the revised manuscript). Although a more robust design might involve randomized induction of fluid intake levels, such an approach would be ethically problematic, as increased fluid intake is recommended by the EFSA guidelines as part of standard clinical practice [1]. We aim to encourage participants to consume approximately 1,500 mL of fluid per day, aligning with clinical recommendations. Providing instructions to limit or alter fluid intake without clinical indication would be inappropriate and unethical. However, we remain vigilant about the potential adverse effects of excessive fluid intake, particularly concerning the risk of heart failure (details provided in the revised Introduction and the left panel of Fig 1B). This concern motivated the design of our study. Although we acknowledge that a randomized controlled approach might be preferable from a purely scientific perspective, we believe that the current study design is the most ‘practical’ and ethically acceptable within the clinical setting.

Comment 1-8.

No background or explanation of the cognitive status questionnaires is given.

Response 1-8:

Thank you for your valuable comment. In accordance with your suggestion, we have added the relevant description in lines 166–179 in the revised manuscript. The MMSE is the most widely used tool for dementia screening [2], primarily assessing learning and memory performance [3]. The FAB is another neuropsychological assessment designed to evaluate frontal lobe function concisely [4], an area in which the MMSE is less sensitive [5]. Both MMSE-J and FAB are scored on scales of 0–30 and 0–18, respectively; lower scores indicate more severe cognitive impairment. These two assessments were selected for the following reasons. First, the MMSE-J is routinely used in our facility as a part of standard clinical practice. Second, the clinical staff are familiar with the FAB, which is less time-consuming and more sensitive to certain cognitive domains that the MMSE may not effectively evaluate [6]. We hope that the revised manuscript satisfactorily addresses the reviewer's concerns.

Comment 1-9.

Number of participants: There are so many missing pieces of data it is difficult to follow the paper. All participants with missing data need to be removed. The abstract makes it appear that the n is almost double of the participants applicable in one of your most important figure (i.e. Figure 1) when the 3 outliers were removed. I am also not convinced the rationale for removing this data is valid.

Response 1-9:

Thank you for your helpful comment. In accordance with your suggestion, we have re-organised the entire manuscript—from the introduction to the discussion. We acknowledge that the original manuscript’s description was somewhat complex, which may have obscured the core objectives. Your feedback highlighted that the study's purpose was not clearly articulated and that essential and trivial information were intertwined. In the revised version, we summarised the main topic into two ‘Themes’, which are visually summarised in the new Fig 1. Simply put, the study was motivated by a clinical question: Should we encourage older individuals to increase fluid intake for better cognition without restrictions? (lines 70–73 in the revised manuscript) Clinicians often hesitate to promote increased fluid intake due to concerns about the risk of heart failure [lines 64–70 in the revised manuscript and the new Fig 1B]. Based on this, we hypothesized that excessive fluid intake might not enhance cognition, drawing an analogy from the relationship between blood volume and cardiac output. It is intuitively understandable that very high fluid intake does not improve MMSE-J scores, as demonstrated by the reversed U-shaped curve in the new Fig 2A (lines 410–413 in the revised manuscript).

In the revised manuscript, all analyses are categorized into three groups:

Theme 1: Comparison between fluid intake and changes in cognitive state

Theme 2A: Comparison between fluid intake and ultrasonographic parameters

Theme 2B: Comparison between cognitive state and ultrasonographic parameters

Theme 2B consists of three sub-comparisons (lines 255–256 in the revised manuscript).

Theme 2b-1: Comparisons at the first assessment

Theme 2B-2: Comparisons at the second assessment

Theme 2B-3: Comparisons of changes between the first and second assessments

(See in the revised Methods)

We eliminated analyses that were not central to our primary objectives.

These five analyses (Theme 1, 2A, 2B-1, 2B-2, and 2B-3) are essentially independent, and mismatches in the number of data points do not influence each other (lines XX–XX in the revised manuscript). Although it is possible to adjust all analyses to the dataset with the smallest number of data points, doing so would result in the loss of valuable information obtainable from the entire dataset. Thus, we chose to utilize the full available dataset, despite some missing data, except for the PI variable. We excluded PI from the revised manuscript due to significant missing data and because it does not provide additional important insights beyond those gained from the other analyses.

We hope we have correctly interpreted the underlying message behind comments 1–9 and have addressed it appropriately in the revised manuscript.

Comment 1-10.

No validation for the instrument used for determining BFP is provided. Did you see high variance in the patients? I may have overlooked where this outcome's data are located, but if no, why not just base relative fluid intake off body mass?

Response 1-10:

Thank you for clarifying regarding the LBM. In accordance with your suggestion, we have added the relevant description in lines 143–147. Distribution of bodily fluids varies across different body components: approximately three-fourths of the total body water is distributed within lean body mass, making it a more appropriate measure for evaluating body size [7–9]. The body fat percentage values were 27.9±8.2% (range: 10.9%–44.8%) at the first assessment and 31.0±7.6%(range: 9.8%–42.1%) at the second. We used a household-use body fat scale, categorised as a health meter. In Japan, the accuracy of such health matters is regulated by the Ministry of Economy, Trade and Industry. Additionally, all the body fat percentages were measured using the same device throughout the study to maintain consistency. Any potential measurement errors should be mitigated during the statistical analyses, even if the device has some inherent inaccuracies.

Comment 1-11.

There is just an overload of tables and figures. It is difficult to follow.

Response 1-11:

Thank you for pointing this out. We completely agree with the reviewer’s perspective and have re-organised the entire manuscript, from the Introduction section to the Discussion section.

We removed unnecessary analyses, figures, and tables, and focused on the data that support the main objectives of the study. The core concept of the study is now accurately illustrated in the revised Fig. 1 and is categorized into two themes. We hope that the revised manuscript effectively conveys our key messages.

Response to Reviewer 2 Comments

Comment 2-1.

Major comments.

The sample size is only 33 individuals, and they are all from a single geriatric health service facility. The sample has a high degree of homogeneity, which may lack broad representativeness. As a result, it is difficult to extrapolate the research findings to a more general elderly population. It is recommended that in future studies, the sample size be expanded and elderly people from different regions and with diverse life backgrounds be included.

Furthermore, It is impossible to assess the patients' fluid intake and dehydration status before admission, which may lead to biases in the research results. Although fluid intake was recorded during the study period, the situation before admission is unknown, which may interfere with the judgment of the relationship between fluid intake and cognition.

Response 2-1:

Thank you for your valuable comment. In accordance with your suggestion, we have revised the manuscript accordingly. With regard to the first point about the ‘homogeneity’ of study participants, we agree with the reviewer and have added this as a limitation in the manuscript (lines 504–507). Specifically, the critical amount of fluid intake is likely to vary among different groups of older individuals. If the present study is published, we plan to expand it by collaborating with other facilities within our hospital network and outside of our group, involving a larger number of participants to obtain more robust and generalizable results.

With regard to the amount of fluid intake prior to admission, we cannot entirely exclude its potential influence on the present results. However, we assume that the severity of dehydration prior to admission was randomly distributed across all participants, and our statistical analyses should have mitigated its effect. Although the uncontrolled levels of dehydration before admission may reduce the sensitivity of our analyses and increase the risk of type II error, we still observed significant correlations between mnFI and changes in cognition and other factors. Thus, believe this limitation is unlikely to substantially impact our main conclusions. We have added this explanation to the Limitations section (lines 507–515 in the revised manuscript).

Comment 2-2.

Abstract: The characteristics of the survey subjects is not well defined. It is unknown whether they are healthy, and if they have chronic diseases. During the research process, it is unclear how many subjects withdrew, and for what reasons. Also, the average age of the subjects and the duration of the study are not provided. The authors just showed the “several months”, three months? Six months? Please clarify.

Response 2-2:

Thank you for your helpful comment. Although we have already described some participant profiles, such as age, sex, and diagnosis, in Tables 1 and 2, we acknowledge that this information was not clearly organized and lacked a distinction between essential and non-essential information details. In the revised manuscript, we present a more concise and structured description of participant characteristics—such as age, sex, weight, lean body mass, and comorbidities—in the main manuscript (lines 96–101 and 276–283) as well as in Table 1. According to the study period (between the first and second assessments), it was 82.6 ± 14.9 days (from 34 to 119 days). Although this was mentioned in the previous version, it was not sufficiently prominent. In the revised manuscript, we have added a new Fig 1 illustrating the study concept and protocol, explicitly including the assessment interval (82.6 ± 14.9 days). Due to clinical limitations and constraints, the duration between assessments varied across participants. To maintain clarity, we have kept the expression ‘several months’ in several places throughout the manuscript.

A total of 33 participants were enrolled in the study, and none of them withdrew from the study. However, some data are missing due to clinical constraints—such as some participants not completing the second assessment by the data collection deadline (23 May 2023)

Attachment

Submitted filename: Response-to-Reviewers.docx

pone.0333793.s002.docx (120.9KB, docx)

Decision Letter 1

Tanja Grubić Kezele

18 Sep 2025

Effect of fluid intake on cognitive function in older individuals: A prospective study

PONE-D-25-10914R1

Dear Dr. Shigihara,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tanja Grubić Kezele, Ph.D., M.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Tanja Grubić Kezele

PONE-D-25-10914R1

PLOS ONE

Dear Dr. Shigihara,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. dr. Tanja Grubić Kezele

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Reviewers comments.doc

    pone.0333793.s001.doc (32.5KB, doc)
    Attachment

    Submitted filename: Response-to-Reviewers.docx

    pone.0333793.s002.docx (120.9KB, docx)

    Data Availability Statement

    All data generated or analysed in this study are openly available in Mendeley Data at Shigihara, Yoshihito (2024), “Fluid intake and cognition”, Mendeley Data, V1, doi: 10.17632/pbj9vcwhfg.1.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES